Close
Translational Research refers to a particular type of research primarily aimed to improve human health. This means using basic knowledge in biology, technology, physics (..) for clinical uses.
- BASIC overview of the translational path
ACCELERATE Potential | UCL School of Life and Medical Sciences - UCL – University College London. This online course is an introduction to the Translational Research and the Translational Path. Self paced, for UCL staff/students and externals.
The Academic Careers Office (ACO) at UCL is part of the Office of the Vice Provost for Health (OVPH). The OVPH's mission is to enhance external relationships in biomedicine with a range of medical research organisations, NHS included. The ACO promotes, supports and develops many aspects of academic in health related disciplines across UCL. As UCL students and researchers at UCL Queen Square IoN, everyone is welcomed to use this resource. ACCELERATE | UCL School of Life and Medical Sciences - UCL – University College London
- ADVANCED overview of therapeutic development by modality: biologics, gene and cell therapy, devices and diagnostics, regenerative medicine, small molecule and repurposingo
Click on the modality you are interested to explore. Roadmaps:
- Biologics Translation Roadmap | UCL Therapeutic Innovation Networks - UCL – University College London
- Cell & Gene Therapy Translation Roadmap | UCL Therapeutic Innovation Networks - UCL – University College London
- Devices Translation Roadmap | UCL Therapeutic Innovation Networks - UCL – University College London
- Regenerative Medicines Case Studies | UCL Therapeutic Innovation Networks - UCL – University College London
- Small Molecules Translation Roadmap | UCL Therapeutic Innovation Networks - UCL – University College London Repurposing | UCL Therapeutic Innovation Networks - UCL – University College LondonLanding page: UCL Therapeutic Innovations Networks (TINs) | UCL Therapeutic Innovation Networks - UCL – University College London.
These resources are offered by the Therapeutic Innovations Networks (TINs @UCL). The TINs is a specific framework embedded in the Translational Research Office (TRO) and partnered with NIHR Biomedical Research Centres (UCLH, Great Ormond Street Hospital, Moorfields eye hospital) for education, training and outreach of early career researchers.
The TRO's main purpose is to support translational research at UCL Translational Research Office | Translational Research Office (TRO) - UCL – University College London.
Webinars: TIN Webinar Recordings | UCL Therapeutic Innovation Networks - UCL – University College London
- FOCUS on the development pathway and regulations of gene, cell and tissue therapy (ATMPs: advanced therapy medical products)
Advanced therapy medicinal products (ATMPs) are medicines for human use that are either a gene therapy medicinal product, a somatic cell therapy medicinal product, or a tissue engineered product. Here you can find informative material from the UK and EU regulatory agency.
- MHRA (UK): Advanced therapy medicinal products: regulation and licensing - GOV.UK (www.gov.uk)
- EMA (EU): Advanced therapy medicinal products: Overview | European Medicines Agency (europa.eu), and also Advanced therapies: research and development | European Medicines Agency (europa.eu)
More webinars and material on ATMPs from London Advanced Therapies in collaboration with NHS- HEE elfh Hub (e-lfh.org.uk)After the initial registration, search for key words such as 'cell/gene therapy'
- Resources • ATTC Network - Advanced Therapy Treatment Centre (theattcnetwork.co.uk) series of talks, case studies and tool kitTalk by Prof Mark Lowdell (UCL) on advancing ATMPs from academia to industry
- ATMPs from academia to industry getting it right first time (GIRFT) | HSTalks
- FOCUS on the development pathway and regulations of small molecules and devices
This presentation was made by Deloitte and published by gov.uk* (2016) as a guide to navigating the innovation pathway in England. It includes development pathways for pharmaceuticals and medical technologies. (*The document is pre-Brexit, therefore some links are not anymore up to date or available. Check with the TRO/TRM if you have specific questions). - Deloitte PowerPoint template (publishing.service.gov.uk).
Oxford also offers some interesting webinars freely available:
Small molecule: How do you get from an idea to a marketed drug? — University of Oxford, Medical Sciences Division. The University of Oxford offers a series of videos to discuss the experience of innovators from pharma (Bayers, Astra Zeneca), but also regulators. Click here you hear about target validation, regulation, commercialisation and investment opportunities.
Devices: Developing a medical device — University of Oxford, Medical Sciences Division. The development of a device follows different regulations compared to a biologic. It is also good practice to have an idea of the category to which the device belongs. The online tool RegMetrics is a digital platform to support health technology innovators in navigating the medical device regulations. The technology was initially developed by the Natural Interaction Lab (NIL) at the University of Oxford, as a solution for a need that was observed within the community of innovators. RegMetrics (reg-metrics.com)- IP (Intellectual property) - UCL resources
UCLB (tech transfer office) follows any development for intellectual property establishment at UCL.
- General policy: UCL Intellectual Property (IP) Policy | Innovation & Enterprise - UCL – University College London
- Commercialisation of an IP and revenue sharing policy at UCL: UCL Revenue Sharing Policy | Innovation & Enterprise - UCL – University College London
- Non-patentable IP: Non-patentable IP: Portico Ventures - Commercialise your research - Our services - UCLBFor any enquires see UCB Q&A Technology transfer – your questions - Forms and resources - UCLB or contact one of the Business Managers: Contact us - UCLB, Find your Business Manager - Contact us - UCLB.
- PPI (Patient and Public involvement)
Evidence of involving patients and the public in the planning, design, management and/or dissemination of research is increasingly a requirement of major funding bodies in the UK. UCL provideS an online PPI helpdesk that researchers can contact Patience for advice on PPI. The helpdesk can be contacted on ppihelpdesk@ucl.ac.uk.
Other resources are:
- The JRO About | About | Joint Research Office - UCL – University College London
- The NIHR UCLH Biomedical Research Centre runs a programme of regular workshops for researchers at UCL Partner organisations on patient and public involvement (PPI) in research. PPI Training | UCLH Biomedical Research Centre (nihr.ac.uk)
- The James Lind Alliance | James Lind Alliance (nihr.ac.uk)
- Charities